Azelby Robert

CIK 00016569989 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001656998

Recent Transactions

50 trades

Award
CARDINAL HEALTH INC$CAH
Common Shares
2024-11-06+1,730→ 3,018 total
Sale
ADC Therapeutics SA$ADCT
Common Shares
2024-06-17$2.89/sh−6,995→ 53,005 total
Award
ADC Therapeutics SA$ADCT
Common Shares
2024-06-13+40,000→ 60,000 total
Award
CARDINAL HEALTH INC$CAH
Common Shares
2024-03-15+1,288→ 1,288 total
Disposition to Issuer
CHINOOK THERAPEUTICS, INC.
Restricted Stock Units
2023-08-11−7,000→ 0 total
Disposition to Issuer
CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy)
2023-08-11$18.40/sh−28,200→ 0 total
Award
CHINOOK THERAPEUTICS, INC.
Stock Option (right to buy)
2023-04-10+28,200→ 28,200 total
Award
CHINOOK THERAPEUTICS, INC.
Restricted Stock (RSU)(Common Stock)
2023-04-10+7,000→ 7,000 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2022-10-31+500,000→ 500,000 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2022-01-27+500,000→ 500,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2021-06-10+42,223→ 42,223 total
Disposition to Issuer
IMMUNOMEDICS INC
Restricted Stock Unit
2020-10-23−3,718→ 0 total
Disposition to Issuer
IMMUNOMEDICS INC
Stock Option (Right to Buy)
2020-10-23−29,040→ 0 total
Award
IMMUNOMEDICS INC
Stock Option (right to buy)
2020-06-18+6,540→ 6,540 total
Award
IMMUNOMEDICS INC
Common Stock, $0.01 par value per share
2020-06-18+3,718→ 3,718 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2020-06-04+40,138→ 40,138 total
Award
IMMUNOMEDICS INC
Stock Option (right to buy)
2020-02-26+22,500→ 22,500 total
Disposition to Issuer
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-10-22−150,000→ 0 total
Disposition to Issuer
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-10-22−505,000→ 0 total
Disposition to Issuer
ALDER BIOPHARMACEUTICALS INC
Restricted Stock Units
2019-10-22−15,000→ 0 total
Disposition to Issuer
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-10-22−1,000,000→ 0 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-06-06+28,882→ 28,882 total
Award
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-04-23+150,000→ 150,000 total
Award
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-02-06+505,000→ 505,000 total
Award
ALDER BIOPHARMACEUTICALS INC
Restricted Stock Units
2019-02-06+15,000→ 15,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2018-10-11+25,848→ 25,848 total
Award
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2018-06-13+1,000,000→ 1,000,000 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−12,437→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−13,927→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−98,545→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−7,500→ 82,112 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−20,580→ 61,532 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−30,002→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-03-05−93,294→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−35,893→ 0 total
Disposition to Issuer
Juno Therapeutics, Inc.
Common Stock
2018-03-05−25,639→ 35,893 total
Sale
Juno Therapeutics, Inc.
Common Stock
2018-02-12$85.55/sh−4,159→ 89,612 total
Sale
Juno Therapeutics, Inc.
Common Stock
2018-02-12$85.55/sh−4,157→ 89,614 total
Sale
Juno Therapeutics, Inc.
Common Stock
2018-02-08$85.77/sh−3,497→ 93,771 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2018-02-08−2,663→ 98,545 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2018-02-08−834→ 30,002 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2018-02-08$25.29/sh+834→ 94,605 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2018-02-08$20.76/sh+2,663→ 97,268 total
Tax Payment
Juno Therapeutics, Inc.
Common Stock
2018-02-07$85.49/sh−2,700→ 93,771 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2018-02-01$51.76/sh+4,167→ 100,638 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2018-02-01−4,167→ 93,294 total
Sale
Juno Therapeutics, Inc.
Common Stock
2018-02-01$85.78/sh−4,167→ 96,471 total
Award
Juno Therapeutics, Inc.
Common Stock
2018-01-31+25,639→ 96,471 total
Exercise/Conversion
Juno Therapeutics, Inc.
Stock Option (Right to Buy)
2018-01-22−102,539→ 97,461 total
Exercise/Conversion
Juno Therapeutics, Inc.
Common Stock
2018-01-22$51.76/sh+102,539→ 173,371 total

Azelby Robert

Recent Transactions

Companies

Recent Filings

Address